by Aleksandar Nikolajevic | Jun 10, 2024 | Newsletter
June 2024 Newsletter Summary:   Change in Tularemia diagnostics: The previous agglutination test procedure is no longer IVDR-compliant and is being discontinued New ELISA procedure: Diagnostics will now be performed using IgM (TUL-M) and IgG (TUL-G) antibody...				
					
			
					
				
															
					
					 by Aleksandar Nikolajevic | Jul 29, 2024 | Newsletter
July 2024 Newsletter Summary:   New test method developed: The Institute of Virology has established a PCR-based test that can distinguish between wild-type measles virus and vaccine virus within one day 498 measles cases in Austria: In the first half of 2024,...				
					
			
					
				
															
					
					 by Aleksandar Nikolajevic | Nov 29, 2024 | Newsletter
November 2024 Newsletter Summary:   Current situation on highly pathogenic avian influenza viruses (HPAIV) H5N1: Several human cases reported in the USA and Canada High H5N1 activity in wild waterfowl and domestic poultry across Europe; numerous poultry farms...				
					
			
					
				
															
					
					 by Aleksandar Nikolajevic | Oct 29, 2024 | Newsletter
October 2024 Newsletter Summary:   Human parainfluenza viruses (HPIV) are among the most common causes of severe respiratory infections in children and rank second after RSV for hospital admissions The four HPIV types show different seasonal patterns – HPIV-3 is...				
					
			
					
				
															
					
					 by Aleksandar Nikolajevic | Sep 29, 2024 | Newsletter
September 2024 Newsletter Summary:   Mpox Clade Ib typing now available in addition to DNA detection Free PCR laboratory testing for cases with justified suspicion and official notification Clinical criteria include non-specific symptoms, maculopapular rash, and...				
					
			
					
				
															
					
					 by Aleksandar Nikolajevic | Aug 29, 2024 | Newsletter
August 2024 Newsletter Summary:   Global increase: WHO reports 7.6 million Dengue cases by April 2024 – significant rise also in Austria with 65 cases in the first quarter of 2024 Symptoms and progression: 75% of infections asymptomatic; symptomatic cases present...